Literature DB >> 9840021

Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.

P Moayyedi1, P L Ragunathan, N Mapstone, A T Axon, D S Tompkins.   

Abstract

Omeprazole 20mg once (od) or twice daily (bd), clarithromycin 250mg bd, and tinidazole 500 mg bd for 7 days (OCT) is an effective regimen against Helicobacter pylori, but the effect of 5-nitroimidazole resistance is unclear. We aimed to evaluate this using the disc diffusion technique and E-test to assess 5-nitroimidazole resistance. H. pylori was cultured from antral biopsies of infected patients as determined by 13C-urea breath test (13C-UBT), histology, and/or rapid urease test. Patients were prescribed OCT, and H. pylori eradication was assessed by 13C-UBT at least 4 weeks after completion of therapy. Antibiotic sensitivities to metronidazole and clarithromycin were evaluated by the disc diffusion method and by minimum inhibitory concentration (MIC) using the E-test. One hundred and forty-one H. pylori-infected patients were enrolled into the study and the organism was successfully cultured in 119 patients (84%). The overall eradication rate was 125/141 (89%). OCT was successful in 62/69 (90%) patients harboring fully sensitive strains of H. pylori compared with 42/45 (93%) of patients with strains that were resistant to metronidazole alone (P = 0.74, Fisher's exact test). MIC was assessed in 22 samples. Using a cut-off point of > 32 microg/ml to define metronidazole resistance, eradication rates were higher against sensitive (9/12; 75%) compared with resistant (3/10; 30%) strains (P = 0.08, Fisher's exact test). 5-Nitroimidazole resistance assessed by the disc diffusion technique is not helpful in predicting OCT failure, but the E-test may be of value.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9840021

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  5 in total

1.  Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in Singapore.

Authors:  Jie-Song Hua; Ho Bow; Peng-Yuan Zheng; Yeoh Khay-Guan
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Clarithromycin resistance in Helicobacter pylori and its clinical relevance.

Authors:  Hua-Xiang Xia; Xue-Gong Fan; Nicholas J Talley
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

Review 3.  Treatment after failure: the problem of "non-responders".

Authors:  J Q Huang; R H Hunt
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

4.  New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China.

Authors:  Qing Hao; Yan Li; Zhi-Jie Zhang; Yong Liu; Hong Gao
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

5.  Susceptibility-guided vs. empiric retreatment of Helicobacter pylori infection after treatment failure.

Authors:  Jacob Yahav; Zmira Samra; Yaron Niv; Charlesnika T Evans; Douglas J Passaro; Gabriel Dinari; Haim Shmuely
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.487

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.